Gen-Probe
Promising Clinical Data on Gen-Probe's APTIMA HPV Test Presented at Major European Medical Meeting
Published in Cancer Weekly, December 2nd, 2008
Gen-Probe's (NASDAQ:GPRO) CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV) infections that are associated with cervical cancer or precancerous lesions, according to nine oral presentations and two scientific posters presented last week by independent and Gen-Probe researchers at the international conference of the European Research Organization on Genital Infection and Neoplasia (EUROGIN) in Nice, France.
Gen-Probe's APTIMA HPV assay has been CE-marked for sale in the European Union, and clinical trials of the test are underway in the United States. The assay has not been approved for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-12-02)
More Articles from Cancer Weekly
- Ardea Biosciences, Inc.
Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results - Breast Cancer
New Patient Study Suggests Siemens Non-Invasive Blood Test May Have a Role in Monitoring Breast Cancer Patients' Response to Herceptin* (trastuzumab) Therapy - Cancer Vaccines
Data on cancer vaccines detailed by J.B. Hansen and co-authors - Cancer Vaccines
New cancer vaccines research reported from K.E. Lasser and co-authors - Cancer Vaccines
Research from L.M. Kollar and co-researchers yields new findings on cancer vaccines - Cancer Vaccines
Research on cancer vaccines reported by A. Berntsen et al - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
